Perrigo on Monday announced it has kicked off a broad industry marketing and communications campaign to raise awareness for, and consumer confidence in, generic over-the-counter store-brand medications.
There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.
Walgreens recently negotiated a 20-year lease agreement here for Walgreens' first university flagship location, said Joey Agree, Agree Realty president and CEO, in a conference call with analysts on Tuesday.
Diplomat Specialty Pharmacy is among several Flint, Mich.-area companies that have signed on to a council to support a local business that makes scrubs and is interested in expanding beyond traditional markets.
Results of a survey indicate a positive response among patients to redesigned patient medication information distributed to patients at retail pharmacy chains in two states as part of an eight-week program.
Five regional retailers — including mass-merchandisers Meijer and Fred Meyer — are selling a mobile point-of-sale credit card processing system compatible with most smartphones and tablets in their stores.
Perrigo announced that it has begun shipments of guaifenesin 600-mg extended-release tablets. It's the first product that is generically equivalent to Reckitt Benckiser's Mucinex 600-mg extended-release tablets.